Gelteq Ltd
GELS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001920092
No open-market purchases or sales by Gelteq Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.3K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Gelteq Ltd changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 6 | 3 | −3 |
| Shares | 94.1K | 85.3K | −8.75K (−9.3%) |
| Value | $129.6K | $68.1K | −$61.5K (−47.4%) |
New holders (1)
Institutions that held Gelteq Ltd at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 51,361 | $41.1K | 0.00% |
Sold out (4)
Institutions that held Gelteq Ltd at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Susquehanna International Group, LLP | 41,550 | $57.3K |
| HRT Financial LP | 15,439 | $21.0K |
| UBS Group AG | 952 | $1.31K |
| Morgan Stanley | 651 | $898 |